The abortion pill is one of the lower-risk medications regulated by the FDA. In the largest rigorous study of medication abortion safety, which tracked over 11,000 patients, only 0.31% experienced a major complication, defined as hospitalization, blood transfusion, or surgery. That means more than 99.5% of patients completed the process without a serious medical event.
That said, “low risk” is not the same as “no risk.” The abortion pill involves real physical symptoms, has specific situations where it should not be used, and carries higher risks when taken without medical guidance. Here’s what the evidence actually shows.
How the Abortion Pill Works
The term “abortion pill” refers to two separate medications taken in sequence. The first, mifepristone, blocks progesterone, the hormone that maintains the uterine lining and sustains early pregnancy. Without progesterone, the lining begins to break down. It also triggers the body to release natural prostaglandins, which cause the uterus to contract.
The second medication, misoprostol, is taken 24 to 48 hours later. It intensifies those contractions, causing the uterus to empty. The combination is approved for use through 10 weeks of pregnancy (70 days from the first day of the last menstrual period).
What the Process Feels Like
Bleeding and cramping are not side effects in the traditional sense. They are the mechanism by which the medication works. Expect bleeding and cramps that last about two weeks. For many people, the heaviest bleeding and most intense cramping occur in the first few hours after taking the second pill. Nausea is also common during this window.
The intensity varies. Some people describe it as similar to a heavy period; others experience cramping significantly worse than a normal cycle. The process is not painless, but it is temporary and manageable for the vast majority of people with over-the-counter pain relievers and a heating pad.
How Rare Serious Complications Are
The 0.31% major complication rate from the California study of over 11,000 patients is consistent with the broader medical literature: medication abortion has a very low rate of serious adverse events when used under medical guidance and within the approved timeframe. The FDA tracks adverse events through a post-marketing surveillance system, and the overall safety profile has remained stable over more than two decades of use in the United States.
The most common serious complication is heavy bleeding that requires intervention. Infection severe enough to cause sepsis is extremely rare. In multiple large studies, no cases of sepsis were reported among patients who followed the standard protocol with medical oversight.
When the Abortion Pill Should Not Be Used
There are specific situations where medication abortion is unsafe. The FDA lists the following contraindications:
- Ectopic pregnancy: A pregnancy located outside the uterus will not be treated by these medications and can become life-threatening if not diagnosed. This is the single most dangerous scenario, because the pills may mask symptoms of a rupturing ectopic pregnancy.
- IUD in place: An intrauterine device must be removed before taking mifepristone.
- Bleeding disorders or blood-thinning medications: Because the process involves significant bleeding, these conditions raise the risk of hemorrhage.
- Adrenal gland problems or long-term corticosteroid use: Mifepristone interacts with cortisol pathways and can disrupt adrenal function.
- Allergy to mifepristone or misoprostol.
- Inherited porphyria: A rare metabolic condition affecting the liver.
This is why screening before a medication abortion matters. Confirming that the pregnancy is in the uterus, that it falls within the approved gestational window, and that none of these conditions apply is what separates a routine experience from a dangerous one.
The Risk of Skipping Medical Guidance
The safety profile described above applies to supervised use. When people take abortion pills purchased without a prescription and without any medical consultation, the complication picture changes significantly. Studies of self-administered pills obtained without medical oversight show higher rates of incomplete abortion, anemia from heavy blood loss, and failed terminations. Ruptured ectopic pregnancies and at least one maternal death have been documented in research on unsupervised self-administration.
The core danger is not the pills themselves but the absence of screening. Without an ultrasound or clinical evaluation, an ectopic pregnancy can go undetected. Without guidance on gestational timing, the pills may be taken too late to work safely. And without knowing what warning signs to watch for, treatable complications can escalate.
Warning Signs That Need Urgent Attention
Most bleeding after a medication abortion is normal, but certain patterns signal a problem. You should seek emergency care if you experience:
- Soaking two or more full-sized maxi pads per hour for two consecutive hours, or passing blood clots larger than a lemon
- Severe pain or cramping that does not improve with pain medication
- Fever of 101°F or higher lasting more than 12 hours, especially if accompanied by chills
- Foul-smelling discharge, which can indicate infection
These situations are uncommon, but recognizing them quickly is important because early treatment for hemorrhage or infection is straightforward and effective.
Effect on Future Fertility
A large study published in the New England Journal of Medicine found no evidence that medication abortion increases the risk of later miscarriage, ectopic pregnancy, preterm birth, or low birth weight. After adjusting for age, time between pregnancies, and other factors, none of these outcomes were more likely in people who had previously had a medication abortion compared to those who had a surgical abortion. The medication does not cause scarring or lasting changes to the uterus, and fertility typically returns within one to two menstrual cycles.
How It’s Regulated in the U.S.
Mifepristone is available only through a special FDA safety program called REMS (Risk Evaluation and Mitigation Strategy). Under this program, prescribers must be certified, patients must sign an agreement confirming they understand the risks, and pharmacies that dispense the medication must also be certified. The pills can be dispensed in person or shipped by mail from a certified pharmacy, but only on a prescription from a certified provider.
The FDA reviewed and updated these requirements in 2023, concluding that the available safety data supported making access somewhat easier, including allowing certified pharmacies to dispense the medication directly, while maintaining the core safeguards of provider certification and patient counseling.